Immunogenicity of infliximab and adalimumab

Expert Opin Drug Saf. 2019 May;18(5):343-345. doi: 10.1080/14740338.2019.1602117. Epub 2019 Apr 16.
No abstract available

Keywords: Infliximab; adalimumab; biosimilars; hypersensitivity reactions; immunogenicity.

Publication types

  • Editorial

MeSH terms

  • Adalimumab / immunology
  • Adalimumab / pharmacology*
  • Antirheumatic Agents / immunology
  • Antirheumatic Agents / pharmacology*
  • Humans
  • Infliximab / immunology
  • Infliximab / pharmacology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab